COVID-19

  1. Rosadas, C., et al. Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility. J Virol Methods.; 302:114475. (2022) https://pubmed.ncbi.nlm.nih.gov/35077719/
  2. Khan, M., et al. Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies. Scientific Reports, 12(1):1885. (2022) https://pubmed.ncbi.nlm.nih.gov/35115570/
  3. Davies, B., et al. Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Non-healthcare Key Workers. Open Forum Infectious Diseases, Volume 8, Issue 11, November 2021. (2021) https://pubmed.ncbi.nlm.nih.gov/34796246/
  4. Sanjay Jain, et al. A new combination testing methodology to identify accurate and economical point-of-care testing strategies. . (2021) https://doi.org/10.1101/2021.06.15.21257351
  5. Moshe M, et al. SARS-CoV-2 lateral flow assays for possible use in covid-19 seroprevalence surveys (REACT 2): diagnostic accuracy study. Br Med J, 37:n423. (2021) https://pubmed.ncbi.nlm.nih.gov/33653694/
Post date
Tuesday, September 24, 2024 - 10:45